NO20061003L - Pyridazinlpiperainer og anvendelse derav som histamin-H3-reseptorligander - Google Patents
Pyridazinlpiperainer og anvendelse derav som histamin-H3-reseptorliganderInfo
- Publication number
- NO20061003L NO20061003L NO20061003A NO20061003A NO20061003L NO 20061003 L NO20061003 L NO 20061003L NO 20061003 A NO20061003 A NO 20061003A NO 20061003 A NO20061003 A NO 20061003A NO 20061003 L NO20061003 L NO 20061003L
- Authority
- NO
- Norway
- Prior art keywords
- histamine
- compounds
- receptor
- piperaines
- pyridazine
- Prior art date
Links
- 102000004384 Histamine H3 receptors Human genes 0.000 title abstract 4
- 108090000981 Histamine H3 receptors Proteins 0.000 title abstract 4
- 239000003446 ligand Substances 0.000 title 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 230000003042 antagnostic effect Effects 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 230000001270 agonistic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000004885 piperazines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301107 | 2003-07-29 | ||
| US49269303P | 2003-08-05 | 2003-08-05 | |
| PCT/DK2004/000483 WO2005009976A1 (fr) | 2003-07-29 | 2004-07-06 | Pyridazinyl-piperazines et leur utilisation en tant que ligands du recepteur histaminique h3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20061003L true NO20061003L (no) | 2006-04-26 |
Family
ID=34105630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20061003A NO20061003L (no) | 2003-07-29 | 2006-02-28 | Pyridazinlpiperainer og anvendelse derav som histamin-H3-reseptorligander |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7294626B2 (fr) |
| EP (1) | EP1651615B1 (fr) |
| JP (1) | JP4680903B2 (fr) |
| KR (1) | KR20060054392A (fr) |
| CN (1) | CN100584831C (fr) |
| AT (1) | ATE461178T1 (fr) |
| AU (1) | AU2004259263B2 (fr) |
| BR (1) | BRPI0413048A (fr) |
| CA (1) | CA2532236C (fr) |
| DE (1) | DE602004026068D1 (fr) |
| DK (1) | DK1651615T3 (fr) |
| ES (1) | ES2342605T3 (fr) |
| IL (1) | IL173161A0 (fr) |
| MX (1) | MXPA06001053A (fr) |
| NO (1) | NO20061003L (fr) |
| PL (1) | PL1651615T3 (fr) |
| PT (1) | PT1651615E (fr) |
| RU (1) | RU2006101452A (fr) |
| WO (1) | WO2005009976A1 (fr) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030176437A1 (en) | 2001-08-31 | 2003-09-18 | D.M. Watterson | Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| US20030236259A1 (en) * | 2002-02-05 | 2003-12-25 | Rolf Hohlweg | Novel aryl- and heteroarylpiperazines |
| CN1972914A (zh) | 2004-03-31 | 2007-05-30 | 詹森药业有限公司 | 作为组胺h3受体配合体的非咪唑杂环化合物 |
| EP1595881A1 (fr) * | 2004-05-12 | 2005-11-16 | Pfizer Limited | Dérivés de tetrahydronaphthyridine en tant que ligands de récepteur H3 d'histamine |
| MX2007003327A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa. |
| TW200626138A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| AR051092A1 (es) | 2004-09-20 | 2006-12-20 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa |
| AR051095A1 (es) * | 2004-09-20 | 2006-12-20 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso comoinhibidores de la estearoil-coa desaturasa |
| CA2580787A1 (fr) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Derives heterocycliques et utilisation de ceux-ci comme agents therapeutiques |
| CN101083992A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 抑制人硬脂酰CoA去饱和酶的哒嗪衍生物 |
| EP2269610A3 (fr) * | 2004-09-20 | 2011-03-09 | Xenon Pharmaceuticals Inc. | Dérivés hétérocycliques et leur utilisation en tant qu'inhibiteurs de la stearoyl-coa desaturase |
| AU2005286648A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| ES2441718T3 (es) | 2004-11-02 | 2014-02-06 | Northwestern University | Compuestos de piridazina, composiciones y métodos |
| WO2006050359A2 (fr) | 2004-11-02 | 2006-05-11 | Northwestern University | Composes pyridazine et methodes |
| CA2618646A1 (fr) | 2005-06-03 | 2007-11-15 | Xenon Pharmaceuticals Inc. | Derives aminothiazole utilises en tant qu'inhibiteurs de la stearoyle-coa desaturase humaine |
| JP5121707B2 (ja) | 2005-07-04 | 2013-01-16 | ハイ ポイント ファーマシューティカルズ，エルエルシー | 新規医薬 |
| GB0517184D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
| JO2769B1 (en) | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor |
| US8158673B2 (en) * | 2005-10-27 | 2012-04-17 | Pfizer Inc. | Histamine-3 receptor antagonists |
| EP2015750A2 (fr) * | 2006-04-28 | 2009-01-21 | Northwestern University | Compositions et traitements utilisant des pyridazines et des inhibiteurs de cholinestérase |
| CN101754762A (zh) | 2006-04-28 | 2010-06-23 | 西北大学 | 用于治疗神经炎症性疾病的包含哒嗪化合物的制剂 |
| JP2009537596A (ja) | 2006-05-23 | 2009-10-29 | ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー | ６−（４−シクロプロピルピペリジン−１−イル）−２’−メチル−［３，４’］−ビピリジン及びその医薬としての使用 |
| SG163547A1 (en) * | 2006-05-29 | 2010-08-30 | High Point Pharmaceuticals Llc | 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist |
| CA2653940C (fr) | 2006-05-30 | 2015-07-14 | Janssen Pharmaceutica N.V. | Composes de pyridyl amide substitues utilises comme modulateurs du recepteur de l'histamine h3 |
| US9108948B2 (en) | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
| BRPI0712823A2 (pt) | 2006-06-23 | 2012-07-24 | Abbott Lab | derivados de ciclopropil amina como moduladores de receptor de histamina h3 |
| JO2642B1 (en) | 2006-12-08 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
| JO2849B1 (en) | 2007-02-13 | 2015-03-15 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
| CN101663292A (zh) | 2007-04-23 | 2010-03-03 | 詹森药业有限公司 | 作为快速解离的多巴胺2受体拮抗剂的4-烷氧基哒嗪衍生物 |
| KR101506156B1 (ko) | 2007-04-23 | 2015-03-26 | 얀센 파마슈티카 엔.브이. | 속해리성 도파민 2 수용체 길항제로서의 티아(디아)졸 |
| CA2687931C (fr) * | 2007-05-31 | 2016-05-24 | Boehringer Ingelheim International Gmbh | Antagonistes des recepteurs ccr2 et utilisations de ceux-ci |
| EP2164519A2 (fr) * | 2007-06-08 | 2010-03-24 | Ascendis Pharma AS | Prodrogues polymériques d'exendin de longue durée d'action |
| EP2014656A3 (fr) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | Nouveaux antagonistes d'hétéocycliques h3 |
| CN105712977B (zh) | 2007-11-20 | 2021-06-29 | 詹森药业有限公司 | 作为组胺h3受体调节剂的环烷基氧基吡啶化合物和杂环烷基氧基吡啶化合物 |
| CA2729313C (fr) | 2008-07-03 | 2016-08-30 | Janssen Pharmaceutica Nv | 6-(1-piperazinyl)-pyridazines substituees comme antagonistes du recepteur 5-ht<sb>6</sb> |
| EA019048B1 (ru) | 2008-07-31 | 2013-12-30 | Янссен Фармацевтика Нв | Пиперазин-1-илтрифторметилзамещенные пиридины в качестве быстро диссоциирующихся антагонистов d-рецепторов дофамина |
| EP2379525B1 (fr) | 2008-12-19 | 2015-07-29 | Boehringer Ingelheim International GmbH | Pyrimidine-4 carboxamides cycliques en tant qu'antagonistes du récepteur ccr2 pour le traitement d'inflammations, de l'asthme et des broncho-pneumopathies chroniques obstructives |
| US9186353B2 (en) | 2009-04-27 | 2015-11-17 | Abbvie Inc. | Treatment of osteoarthritis pain |
| ES2524829T3 (es) | 2009-12-17 | 2014-12-12 | Boehringer Ingelheim International Gmbh | Nuevos antagonistas del receptor CCR2 y usos de los mismos |
| JP2013526507A (ja) | 2010-05-12 | 2013-06-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規ｃｃｒ２受容体アンタゴニスト、その製造方法及び薬物としてのその使用 |
| WO2011141477A1 (fr) | 2010-05-12 | 2011-11-17 | Boehringer Ingelheim International Gmbh | Nouveaux antagonistes du récepteur ccr2, leur procédé de production et leur utilisation en tant que médicaments |
| EP2571870B1 (fr) | 2010-05-17 | 2015-01-21 | Boehringer Ingelheim International GmbH | Antagonistes de ccr2 et leurs utilisations |
| US9018212B2 (en) * | 2010-05-25 | 2015-04-28 | Boehringer Ingelheim International Gmbh | Pyridazine carboxamides as CCR2 receptor antagonists |
| US8962656B2 (en) | 2010-06-01 | 2015-02-24 | Boehringer Ingelheim International Gmbh | CCR2 antagonists |
| WO2012037258A1 (fr) | 2010-09-16 | 2012-03-22 | Abbott Laboratories | Procédés de préparation de dérivés cyclopropyliques substitués en 1,2 |
| EP2731941B1 (fr) | 2011-07-15 | 2019-05-08 | Boehringer Ingelheim International GmbH | Antagonistes ccr2, nouveaux et sélectifs |
| WO2013151982A1 (fr) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Méthodes et composés utiles pour traiter le prurit, et procédés d'identification desdits composés |
| FR2999427B1 (fr) * | 2012-12-17 | 2015-01-30 | Metabolys | Composition et kit comprenant des derives de piperazine et de la metformine, leur utilisation dans le traitement du diabete |
| AU2016287584B2 (en) | 2015-07-02 | 2020-03-26 | Centrexion Therapeutics Corporation | (4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4yl)methanone citrate |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4144346A (en) | 1977-01-31 | 1979-03-13 | Janssen Pharmaceutica N.V. | Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
| FR2573075B1 (fr) * | 1984-09-14 | 1987-03-20 | Innothera Lab Sa | Nouvelles (pyridyl-2)-1 piperazines, leur procede de preparation et leur application en therapeutique |
| GEP20032896B (en) | 1997-10-27 | 2003-02-25 | Agouron Pharma | 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment |
| WO2000066578A1 (fr) | 1999-04-30 | 2000-11-09 | Pfizer Products Inc. | Composes pour le traitement de l'obesite |
| WO2001066534A2 (fr) | 2000-03-09 | 2001-09-13 | Abbott Laboratories | Antagonistes du recepteur d'histamine-3 diamino cycliques et bicycliques |
| WO2001074810A2 (fr) | 2000-03-31 | 2001-10-11 | Ortho Mcneil Pharmaceutical, Inc. | Procede d'utilisation de 2-aryloxyalkylaminobenzoxazoles et de 2-aryloxyalkylaminobenzothiazoles comme antagonistes vis-a-vis du recepteur h3 |
| US6316475B1 (en) * | 2000-11-17 | 2001-11-13 | Abbott Laboratories | Aminoalkoxybiphenylcarboxamides as histamine-3 receptor ligands and their therapeutic applications |
| MXPA04007612A (es) * | 2002-02-05 | 2004-11-10 | Novo Nordisk As | Aril- y heteroarilpiperazinas novedosas. |
-
2004
- 2004-07-06 CN CN200480021891A patent/CN100584831C/zh not_active Expired - Fee Related
- 2004-07-06 EP EP04738980A patent/EP1651615B1/fr not_active Not-in-force
- 2004-07-06 PL PL04738980T patent/PL1651615T3/pl unknown
- 2004-07-06 AT AT04738980T patent/ATE461178T1/de active
- 2004-07-06 RU RU2006101452/04A patent/RU2006101452A/ru not_active Application Discontinuation
- 2004-07-06 PT PT04738980T patent/PT1651615E/pt unknown
- 2004-07-06 DK DK04738980.4T patent/DK1651615T3/da active
- 2004-07-06 WO PCT/DK2004/000483 patent/WO2005009976A1/fr active Application Filing
- 2004-07-06 DE DE602004026068T patent/DE602004026068D1/de active Active
- 2004-07-06 MX MXPA06001053A patent/MXPA06001053A/es active IP Right Grant
- 2004-07-06 ES ES04738980T patent/ES2342605T3/es active Active
- 2004-07-06 JP JP2006521396A patent/JP4680903B2/ja not_active Expired - Fee Related
- 2004-07-06 CA CA2532236A patent/CA2532236C/fr not_active Expired - Fee Related
- 2004-07-06 AU AU2004259263A patent/AU2004259263B2/en not_active Ceased
- 2004-07-06 BR BRPI0413048-0A patent/BRPI0413048A/pt not_active IP Right Cessation
- 2004-07-06 KR KR1020067002114A patent/KR20060054392A/ko not_active Application Discontinuation
-
2006
- 2006-01-16 IL IL173161A patent/IL173161A0/en unknown
- 2006-01-18 US US11/334,207 patent/US7294626B2/en not_active Expired - Fee Related
- 2006-02-28 NO NO20061003A patent/NO20061003L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN100584831C (zh) | 2010-01-27 |
| PL1651615T3 (pl) | 2010-08-31 |
| IL173161A0 (en) | 2006-06-11 |
| EP1651615B1 (fr) | 2010-03-17 |
| AU2004259263A1 (en) | 2005-02-03 |
| PT1651615E (pt) | 2010-04-29 |
| MXPA06001053A (es) | 2006-04-11 |
| US7294626B2 (en) | 2007-11-13 |
| CA2532236A1 (fr) | 2005-02-03 |
| CN1829699A (zh) | 2006-09-06 |
| ATE461178T1 (de) | 2010-04-15 |
| EP1651615A1 (fr) | 2006-05-03 |
| KR20060054392A (ko) | 2006-05-22 |
| US20060173012A1 (en) | 2006-08-03 |
| ES2342605T3 (es) | 2010-07-09 |
| JP2007500135A (ja) | 2007-01-11 |
| JP4680903B2 (ja) | 2011-05-11 |
| CA2532236C (fr) | 2011-08-23 |
| DE602004026068D1 (de) | 2010-04-29 |
| AU2004259263B2 (en) | 2010-12-16 |
| DK1651615T3 (da) | 2010-05-25 |
| WO2005009976A1 (fr) | 2005-02-03 |
| BRPI0413048A (pt) | 2006-10-17 |
| RU2006101452A (ru) | 2006-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20061003L (no) | Pyridazinlpiperainer og anvendelse derav som histamin-H3-reseptorligander | |
| WO2003066604A3 (fr) | Nouvelles aryl- et heteroarylpiperazines | |
| DE60237528D1 (de) | Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative | |
| CR9304A (es) | Antagonistas del receptor de glucagon, preparaciones y usos terapeuticos | |
| DK1735278T3 (da) | Histamin H3-receptormidler, fremstilling og terapeutiske anvendelser | |
| NO20075624L (no) | Nye histamin H3-reseptorligander og deres terapeutiske anvendelser | |
| NO20055837L (no) | Immunsupprimerende forbindelser og sammensetninger | |
| DK1957484T3 (da) | Glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser | |
| EA200601897A1 (ru) | Производные тетрагидронафтиридина, пригодные в качестве лигандов рецептора н3 гистамина | |
| NO341523B1 (no) | Benzoimidazol-2-ylpyrimidiner og -pyraziner som modulatorer av histamin H4-reseptoren, farmasøytisk sammensetning samt anvendelse | |
| GB0222495D0 (en) | Compounds | |
| TW200611695A (en) | Pyrrolopyridine derivatives | |
| DK1758853T3 (da) | Glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser | |
| NO20043637L (no) | Amider av aminoalkylsubstituerte azetidiner, pyrrolidiner, piperidiner og azepaner | |
| TW200800946A (en) | Substituted piperazines as metabotropic glutamate receptor antagonists | |
| DK1951659T3 (da) | Glucagonreceptorantagonister, fremstilling og terapeutisk anvendelse heraf | |
| ATE442846T1 (de) | Piperidin- und pyrrolidin-derivate alsantagonisten des histamin-h3-rezeptors | |
| DE602005009500D1 (de) | Pyridinderivate und deren verwendung als modulatoren des cb2-rezeptors | |
| ATE481972T1 (de) | Chinazolinon-derivate als vanilloid-antagonisten | |
| SE0300457D0 (sv) | Novel compounds | |
| ATE455095T1 (de) | Vanilloidrezeptor trpv1-antagonisten | |
| DE60322110D1 (de) | Substituierte 4-(4-piperidin-yl-piperazin-1-yl)-azntagonisten | |
| UA83187C2 (en) | Aryl- and heteroarylpiperazines | |
| ATE483710T1 (de) | Isochinolin-3-carbonsäureamide und ihre pharmazeutische verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |